Rating Change
Needham analysts initiated coverage on CARLSMED, INC. (NASDAQ:CARL) with a Buy rating on July 01, 2026.
new coverageNASDAQ:CARL
Needham Initiates Coverage on CARLSMED, INC. (CARL) with Buy
Rating Change Needham analysts initiated coverage on CARLSMED, INC. (NASDAQ:CARL) with a Buy rating on July 01, 2026. Market Context CARLSMED, INC.
Market Context
CARLSMED, INC. operates in the Healthcare sector. The stock currently trades at $11.73 with a market capitalization of $348.6M.
Analyst coverage from Needham provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for CARLSMED, INC..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for CARLSMED, INC.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 01, 2026 | Needham | Buy | N/A |
| May 06, 2026 | BTIG | Buy | N/A |
| Apr 15, 2026 | Truist Securities | Buy | N/A |
| Apr 09, 2026 | Goldman Sachs | Buy | N/A |
| Dec 15, 2025 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View CARL Stock Page
Frequently Asked Questions
What does a Buy rating mean for CARL?
A Buy rating from Needham reflects the analyst's outlook on CARLSMED, INC. (NASDAQ:CARL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CARL forecast page.